The selection of the phCEA, a marker to detect the presence of cancer cells of epithelial origin is specific for various types of cancer including colorectal cancer44,69, supports the concept that CEA is one of the most promising target antigens for colorectal cancer immunotherapy in use. Here, CEACAM5 is linked to colorectal cancer.